What is a crossover trial?

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Sedgwick, Philip ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRONABINOL; PARACETAMOL; PLACEBO; CANNABINOID RECEPTOR AGONIST;

CLINICAL STUDY; CROSSOVER PROCEDURE (TOPIC); DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; NOTE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; STUDY DESIGN; TREATMENT DURATION; TREATMENT RESPONSE; CROSSOVER PROCEDURE; METHODOLOGY; NEURALGIA;

CANNABINOID RECEPTOR AGONISTS; CROSS-OVER STUDIES; DRONABINOL; HUMANS; MULTIPLE SCLEROSIS; NEURALGIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84900461339     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3191     Document Type: Note

References (2)

1. Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 2004;329:253.
2. Sedgwick P. What is an "n-of-1" trial? BMJ 2014;348:g2674.